Prospective, Non-interventional Study on the Real-World Use of Certoparin in …

We aimed to verify safety and effectiveness of certoparin real-world use and to identify predictors of thromboembolic events or bleeding. Methods: This was a non-interventional study documenting patients at hospital- or office-based physicians. Results: Patients’ (n ¼ 1407) mean age was 53.7+16.1 years. Reason for certoparin use was prophylaxis of venous thromboembolism in 1331 (94.6%) patie…